100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Test Bank - Lilleys Pharmacology for Canadian Health Care Practice, 4th Edition (Sealock, 2021), Chapter 1-58 | All Chapters $17.99   Add to cart

Exam (elaborations)

Test Bank - Lilleys Pharmacology for Canadian Health Care Practice, 4th Edition (Sealock, 2021), Chapter 1-58 | All Chapters

 5 views  0 purchase
  • Course
  • Institution
  • Book

Test Bank - Lilleys Pharmacology for Canadian Health Care Practice, 4th Edition (Sealock, 2021), Chapter 1-58 | All Chapters

Preview 6 out of 134  pages

  • October 25, 2023
  • 134
  • 2023/2024
  • Exam (elaborations)
  • Questions & answers
avatar-seller
lOMoAR cPSD| 30089585




lOMoAR cPSD| 30089585




Lilley’s Pharmacology for Canadian Health Care Practice
Sealock TEST BANK

, lOMoAR cPSD| 30089585




Chapter 01: Nursing Practice in Canada and Drug Therapy
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition


MULTIPLE CHOICE

1. Which is a judgement about a particular patient’s potential need or problem?
a. A goal
b. An assessment
c. Subjective data
d. A nursing diagnosis
ANS: D
Nursing diagnosis is the phase of the nursing process during which a clinical judgement is made about
heath conditions and life processes or vulnerability for that response.

DIF: Cognitive Level: Knowledge

2. The patient is to receive oral furosemide (Lasix) every day; however, because the patient is unable to s
medication orally, as ordered. The nurse needs to contact the physician. What type of problem is this?
a. A “right time” problem
b. A “right dose” problem
c. A “right route” problem
d. A “right medication” problem
ANS: C
This is a “right route” problem: the nurse cannot assume the route and must clarify the route with the p
time” problem because the ordered frequency has not changed. This is not a “right dose” problem beca
an inability to swallow. This is not a “right medication” problem because the medication ordered will n

DIF: Cognitive Level: Application

3. The nurse has been monitoring the patient’s progress on his new drug regimen since the first dose and
of possible adverse effects. What nursing process phase is the nurse practising?
a. Planning
b. Evaluation
c. Implementation
d. Nursing diagnosis
ANS: B
Monitoring the patient’s progress is part of the evaluation phase. Planning, implementation, and nursin
illustrated by this example.

DIF: Cognitive Level: Application

4. The nurse is caring for a patient who has been newly diagnosed with type 1 diabetes mellitus. Which st
outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient adheres to the new insulin treatment regimen.
d. The patient demonstrates safe insulin self-administration technique.
ANS: D
Having the patient demonstrate safe insulin self-administration technique is a specific and measurable
instructions and avoiding complications are not specific criteria. Adherence to the new insulin treatmen
and would be difficult to measure.

DIF: Cognitive Level: Application

, lOMoAR cPSD| 30089585




DIF: Cognitive Level: Application | Cognitive Level: Analysis

7. Which constitutes the traditional Five Rights of medication administration?
a. Right drug, right route, right dose, right time, and right patient
b. Right drug, the right effect, the right route, the right time, and the right patient
c. Right patient, right strength, right diagnosis, right drug, and right route
d. Right patient, right diagnosis, right drug, right route, and right time
ANS: A
The traditional Five Rights of medication administration were considered to be Right drug, Right route
Right patient. Right effect, right strength, and right diagnosis are not part of the traditional Five Rights

DIF: Cognitive Level: Comprehension

8. What correctly describes the nursing process?
a. Diagnosing, planning, assessing, implementing, and finally evaluating
b. Assessing, then diagnosing, implementing, and ending with evaluating
c. A linear direction that begins with assessing and continues through diagnosing,
planning, and finally implementing
d. An ongoing process that begins with assessing and continues with diagnosing,
planning, implementing, and evaluating
ANS: D
The nursing process is an ongoing, flexible, adaptable, and adjustable five-step process that begins with
through diagnosing, planning, implementing, and finally evaluating, which may then lead back to any o

DIF: Cognitive Level: Application

9. When the nurse is considering the timing of a drug dose, which is most important to assess?
a. The patient’s identification
b. The patient’s weight
c. The patient’s last meal
d. Any drug or food allergies
ANS: C
The pharmacokinetic and pharmacodynamic properties of the drug need to be assessed with regard to a
compatibility issues. The patient’s identification, weight, and drug or food allergies are not affected by

DIF: Cognitive Level: Application

10. The nurse is writing nursing diagnoses for a plan of care. Which reflects the correct format for her nurs
a. Anxiety
b. Anxiety related to new drug therapy
c. Anxiety related to anxious feelings about drug therapy, as evidenced by
statements such as “I’m upset about having to give myself shots”
d. Anxiety related to new drug therapy, as evidenced by statements such as “I’m
upset about having to give myself shots”
ANS: D
Formulation of nursing diagnoses is usually a three-step process. The only complete answer is “Anxiet
therapy, as evidenced by statements such as ‘I’m upset about having to give myself shots.’” The answe
“related to” and “as evidenced by” portions. The answer “Anxiety related to new drug therapy” is miss
portion of defining characteristics. The “related to” section in “Anxiety related to anxious feelings abou
by statements such as ‘I’m upset about having to give myself shots’” is simply a restatement of the pro
separate factor related to the response.

DIF: Cognitive Level: Analysis


OTHER

, lOMoAR cPSD| 30089585




Chapter 02: Pharmacological Principles
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition


MULTIPLE CHOICE

1. A patient is receiving two different drugs, which, at their current dose forms and dosages, are both abso
identical amounts. Which term best denotes that the drugs have the same absorption rates?
a. Equivalent
b. Synergistic
c. Compatible
d. Bioequivalent
ANS: D
Two drugs absorbed into the circulation at the same amount (in specific dosage forms) have the same b
bioequivalent. “Equivalent” is incorrect because the term “bioavailability” is used to express the extent
“Synergistic” is incorrect because this term refers to two drugs given together whose resulting effect is
effects of each drug given alone. “Compatible” is incorrect because this term is a general term used to
do not have a chemical reaction when mixed (or given, in the case of drugs) together.

DIF: Cognitive Level: Comprehension

2. A patient is receiving medication via intravenous injection. Which information should the nurse provid
a. The medication will cause fewer adverse effects when given intravenously.
b. The medication will be absorbed slowly into the tissues over time.
c. The medication’s action will begin faster when given intravenously.
d. Most of the drug is inactivated by the liver before it reaches the target area.
ANS: C
Intravenous injections are the fastest route of absorption. The intravenous route does not affect the num
intravenous route is not a slow route of absorption, and the intravenous route does not cause inactivatio
before it reaches the target area.

DIF: Cognitive Level: Comprehension

3. Which is true regarding parenteral drugs?
a. They bypass the first-pass effect.
b. They decrease blood flow to the stomach.
c. They are altered by the presence of food in the stomach.
d. They exert their effects while circulating in the bloodstream.
ANS: A
Drugs given by the parenteral route bypass the first-pass effect, but they still must be absorbed into cel
exert their effects. Enteral drugs (drugs taken orally), not parenteral drugs, decrease blood flow to the s
the presence of food in the stomach. Parenteral drugs must be absorbed into cells and tissues from the c
exert their effects; they do not exert their effects while circulating in the bloodstream.

DIF: Cognitive Level: Analysis

4. A drug’s half-life is best defined as
a. The time it takes for the drug to elicit half its therapeutic response.
b. The time it takes one-half of the original amount of a drug to reach the target
cells.
c. The time it takes one-half of the original amount of a drug to be removed from the
body.
d. The time it takes one-half of the original amount of a drug to be absorbed into the
circulation.
ANS: C
A drug’s half-life is the time it takes for one-half of the original amount of a drug to be removed from t

, lOMoAR cPSD| 30089585




6. A drug interacts with enzymes by
a. altering cell membrane permeability.
b. “fooling” a receptor on the cell wall.
c. enhancing the drug’s effectiveness within the cells.
d. “fooling” the enzyme into binding with it instead of its normal target cell.
ANS: D
When drugs interact with enzymes, they inhibit the action of a specific enzyme by “fooling” the enzym
of to its normal target cell. Thus, the target cells are protected from the action of the enzymes to result
alteration of cell membrane permeability, the “fooling” of a receptor on the cell wall, and the enhancem
drugs within cells do not occur with selective enzyme interactions.

DIF: Cognitive Level: Comprehension

7. When administering a new medication to a patient, the nurse reads that it is highly protein bound. Whic
from this protein binding?
a. Renal excretion will take longer.
b. The drug will be metabolized quickly.
c. The duration of action of the medication will be longer.
d. The duration of action of the medication will be shorter.
ANS: C
Drugs that are bound to plasma proteins are characterized by a longer duration of action. Protein bindin
excretion longer and does not increase metabolism of the drug. Protein binding of a drug means that th
longer, not shorter.

DIF: Cognitive Level: Application

8. When monitoring a patient on an insulin drip to reduce blood glucose levels, the nurse notes that the pa
extremely low, and the patient is lethargic and difficult to awaken. Which adverse drug reaction is the n
a. An adverse effect
b. An allergic reaction
c. An idiosyncratic reaction
d. A pharmacological reaction
ANS: D
A pharmacological reaction is an extension of the drug’s normal effects in the body. In this case, the in
blood glucose levels too much. An adverse effect is a predictable, well-known adverse drug reaction th
changes in patient management. An allergic reaction (also known as a hypersensitivity reaction) involv
system. An idiosyncratic reaction is unexpected and is defined as a genetically determined abnormal re
a drug.

DIF: Cognitive Level: Comprehension

9. A patient is experiencing chest pain and needs to take a sublingual form of nitroglycerin. Where should
place the tablet?
a. Under the tongue
b. In the space between the cheek and gum
c. At the back of the throat, for easy swallowing
d. On a non-hairy area on the chest
ANS: A
Drugs taken by the sublingual route are placed under the tongue. Placing the tablet in the space betwee
for the buccal route; placing the tablet at the back of the throat (for easy swallowing) is done in the ora
on a non-hairy area on the chest is done in the topical or transdermal route.

DIF: Cognitive Level: Comprehension

10. The nurse is administering medications to a patient who is in liver failure due to end-stage cirrhosis. Th
patients with liver failure are most likely to have problems with which pharmacokinetic phase?

, lOMoAR cPSD| 30089585




Chapter 03: Legal and Ethical Considerations
Sealock: Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition


MULTIPLE CHOICE

1. In the development of a new drug by a pharmaceutical company, the researcher must ensure that the pa
drug studies do not have unrealistic expectations of the new drug’s usefulness. What will the researche
study to prevent bias that may occur?
a. A placebo
b. Health Canada approval
c. Informed consent
d. Efficacy information
ANS: A
To prevent bias that may occur as a result of unrealistic expectations of an investigational new drug, a p
into the study. Health Canada approval, if given, does not be obtained until after phase III of the study.
required in all drug studies. Efficacy information is not determined until the study is under way.

DIF: Cognitive Level: Comprehension

2. A member of an investigational drug study team is working with healthy volunteers whose participatio
optimal dosage range and pharmacokinetics of the drug. In what type of study is the team member part
a. Phase I
b. Phase II
c. Phase III
d. Phase IV
ANS: A
Phase I studies involve small numbers of healthy volunteers to determine the optimal dosage range and
drug. Phases II, III, and IV involve progressively larger numbers of volunteers who have the disease or
designed to diagnose or treat.

DIF: Cognitive Level: Application

3. A patient has a prescription for a drug classified as Schedule F. What important information should the
obtaining refills for this medication?
a. No prescription refills are permitted.
b. Refills may be obtained via telephone order.
c. Refills are indicated by the prescriber.
d. The patient may have no more than six refills in a 12-month period.
ANS: C
Schedule F contains a list of drugs that can be sold and refilled only on prescription; prescriptions can b
indicated by the prescriber.

DIF: Cognitive Level: Analysis

4. A patient has been chosen to be a recipient of an investigational drug for heart failure and has given inf
indicated by the patient’s informed consent?
a. The patient has been informed of the possible benefits of the new therapy.
b. The patient will be informed of the details of the study as the research continues.
c. The patient will not be assured of receiving the actual drug during the experiment.
d. The patient has received an explanation of the study’s purpose, procedures, and
the benefits and risks involved.
ANS: D
Informed consent involves the careful explanation of the purpose of the study, procedures to be used, a
risks involved. Being informed of the possible benefits of the new therapy, being informed of the study
continues, and being assured of receiving the actual drug during the experiment do not describe inform

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller EXPERTSCHAPTER. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $17.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

79064 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling

Recently viewed by you


$17.99
  • (0)
  Add to cart